BIOVERIFY Trademark

Trademark Overview

On Monday, April 27, 2026, a trademark application was filed for BIOVERIFY with the United States Patent and Trademark Office. The USPTO has given the BIOVERIFY trademark a serial number of 99788594. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 27, 2026. This trademark is owned by Clinical Trial Media Inc.. The BIOVERIFY trademark is filed in the Advertising, Business and Retail Services category with the following description:

Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
bioverify

General Information

Serial Number99788594
Word MarkBIOVERIFY
Filing DateMonday, April 27, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, April 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkBIO VERIFY
Goods and ServicesRecruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, April 27, 2026
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameClinical Trial Media Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHauppauge, NY 11788
US

Trademark Events

Event DateEvent Description
Monday, April 27, 2026NEW APPLICATION ENTERED
Monday, April 27, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

bioverify clinical patients recruiting participation trials drugs testing purpose notices services